AB
Healthcare & Life Sciences
Alder Biopharmaceuticals
Alder Biopharmaceuticals is a Healthcare & Life Sciences startup, most recent round Series C+, 2 tracked investors.
series-c-plus
series-c-plus
Stage
2
Investors
About Alder Biopharmaceuticals
Alder Biopharmaceuticals is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Alder Biopharmaceuticals identifies, develops, and manufactures novel antibody therapeutics targeting autoimmune and inflammatory diseases.
Explore Alder Biopharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.